Kestra Medical Technologies, Ltd. - Common Stock (NQ:KMTS)

27.43 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kestra Medical Technologies, Ltd. - Common Stock

< Previous 1 2 Next >

Kestra (KMTS) Q1 2027 Earnings Call Transcript ↗

September 15, 2026

Gross margins hit 56.5% as revenue surged 60% and management raised full-year guidance.

Via The Motley Fool

Topics Earnings Supply Chain

Kestra Medical Technologies Q1 Earnings Call Highlights ↗

September 14, 2026

Kestra Medical Technologies (NASDAQ:KMTS) reported first-quarter fiscal 2027 revenue of $31 million, with President and Chief Executive Officer Brian Webster saying revenue rose 60% from a year earlier...

Via MarketBeat

Topics Earnings

What's going on in today's after hours session ↗

September 14, 2026

Via Chartmill

Kestra Medical Technologies (NASDAQ:KMTS) Revenue Beat and EPS Miss Create Mixed Setup After Recent Rally ↗

July 14, 2026

Via Chartmill

Kestra Medical Technologies (NASDAQ:KMTS) Reports Q3 Revenue Beat but Stock Falls on In-Line Losses ↗

March 17, 2026

Via Chartmill

Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript ↗

July 14, 2026

Revenue surged 66% in Q4 as prescriptions climbed 63% year over year.

Via The Motley Fool

Topics Earnings

Kestra Medical Technologies Q4 Earnings Call Highlights ↗

July 14, 2026

Kestra Medical Technologies (NASDAQ:KMTS) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s...

Via MarketBeat

Topics Earnings

What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains ↗

June 24, 2026

This cardiac device innovator saw a notable insider sale, as routine portfolio moves continue amid its push in digital health solutions.

Via The Motley Fool

Topics Regulatory Compliance

Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet ↗

May 15, 2026

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and institutions.

Via The Motley Fool

Topics Regulatory Compliance

Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗

May 15, 2026

Alumis Inc. develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases using allosteric TYK2 inhibitors.

Via The Motley Fool

Topics Regulatory Compliance

Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares ↗

May 15, 2026

Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.

Via The Motley Fool

Topics Regulatory Compliance

The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock ↗

April 03, 2026

Kestra Medical Technologies, a specialist in wearable cardiac devices, reported a recent insider buy amid a year of share price declines.

Via The Motley Fool

Topics Derivatives Regulatory Compliance

Kestra Medical (KMTS) Q3 2026 Earnings Transcript ↗

March 17, 2026

Kestra Medical (KMTS) Q3 2026 Earnings Transcript

Via The Motley Fool

Topics Initial Public Offering

Get insights into the top gainers and losers of Friday's pre-market session. ↗

January 16, 2026

Via Chartmill

Kestra Medical (KMTS) Q2 2026 Earnings Transcript ↗

December 11, 2025

Kestra Medical (KMTS) Q2 2026 Earnings Transcript

Via The Motley Fool

Topics Initial Public Offering

Kestra Medical Technologies (NASDAQ:KMTS) Posts Mixed Q2 2026 Results, Shares Drop on Wider Loss ↗

December 11, 2025

Kestra Medical beats Q2 2026 revenue estimates but posts a wider-than-expected loss, triggering a sharp after-hours stock decline.

Via Chartmill

This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

November 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 11, 2025

Via Benzinga

Kestra Revenue Jumps 52% in Fiscal Q1 ↗

September 11, 2025

Via The Motley Fool

Wondering what's happening in today's after-hours session? ↗

September 11, 2025

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

KESTRA MEDICAL TECHNOLOGIES (NASDAQ:KMTS) Surpasses Q1 2026 Earnings and Revenue Estimates ↗

September 11, 2025

Kestra Medical beats Q1 FY26 revenue and EPS estimates, sending its stock up nearly 9% in after-hours trading on strong operational performance.

Via Chartmill

Earnings Scheduled For September 11, 2025 ↗

September 11, 2025

Via Benzinga

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

August 04, 2025

From RxSight, Inc.

Via GlobeNewswire

Tuesday's after hours session: top gainers and losers ↗

July 15, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

July 15, 2025

From Kestra Medical Technologies, Ltd.

Via GlobeNewswire

Earnings Scheduled For July 15, 2025 ↗

July 15, 2025

Via Benzinga

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist

May 13, 2025

From Kestra Medical Technologies, Ltd.

Via GlobeNewswire

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

April 30, 2025

From Kestra Medical Technologies, Ltd.

Via GlobeNewswire

Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

April 29, 2025

New data highlights strong wear compliance, meaningful arrhythmia detection, and continuity of care in community-based advanced practice provider-driven model

From Kestra Medical Technologies, Ltd.

Via GlobeNewswire

Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025

April 23, 2025

Company to spotlight ASSURE WCD performance and expanded clinical applications

From Kestra Medical Technologies, Ltd.

Via GlobeNewswire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.